Study of the Carrier State for Five BRCA1/BRCA2 Deleterious Mutations in Bulgarian Women with Breast Cancer

1. Bulgarian national cancer registry. Cancer incidence in Bulgaria - data for 2010. [cited 2013 Nov 2]. Available from: http://www.sbaloncology.bg/en/ncr.htmlSearch in Google Scholar

2. Broca P, Traite’ des tumeurs. Paris: P. Asselin; 1866.Search in Google Scholar

3. Collaborative Group on Hormonal Factors idisease. Lancet 2001 ;358(9291 ):1389-99.10.1016/S0140-6736(01)06524-2Search in Google Scholar

4. Thompson D, Easton D.The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia. 2 004;9(3 ):221-36.10.1023/B:JOMG.0000048770.90334.3bSearch in Google Scholar

5. American College of Obstetricians and Gynecologists; ACOG Committee on Practice Bulletins-Gynecology; ACOG Committee on Genetics; Society of Gynecologic Oncologists. ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome. Obstet Gy necol 2009; 113(4):957-66.10.1097/AOG.0b013e3181a106d419305347Search in Google Scholar

6. National Cancer Institute [Internet]. Genetic testing for hereditary cancer syndromes, [updated 2013 Oct 4; cited 2013 Nov 2]. Available from: http://vvww.cancer.gov/cancertopics/fact.sheet/Risk/genetic-testingSearch in Google Scholar

7. Hughes KS, Ravnikar V. Risk assessment and management of women with BRCA mutations. A Supplement to The Female Patient. 2009, Nov.Search in Google Scholar

8. National Cancer Center Network. Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and (Xarian. [cited 2013 Nov 2]. Available at: www.nccn.org/professionals/physician_gls/PDF7genetics_screening.pdf.Search in Google Scholar

9. Wooster R, Weber BL. Breast and ovarian cancer. NEnglJ Med. 2003;48(23):2339-47.10.1056/NEJMra01228412788999Search in Google Scholar

10. Lakhani SR, Jacquemier J, Sloan JP, Gusterson BA, Anderson TJ, van de Vijver MJ, et al. Multi factorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Insl 1998;90( 15): 1138-45.Search in Google Scholar

11. Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer. 2004;4<9): 665-76.10.1038/nrc143115343273Search in Google Scholar

12. Agnarsson BA, Jonasson JG, Bjomsdottir IB, Barkardottir RB, Egilsson V, Sigurdsson H. Inherited BRCA2 mutation associated with high grade breast cancer. Breast Cancer Res Treat. 1998;4 7(2): 121 -7.10.1023/A:1005853022804Search in Google Scholar

13. National Human Genome research Institute [Internet]. Breast cancer information core Breast cancer, [cited 2013 Nov 2]. Available from: http://research.nhgri.nih.gov/projectsbic/Search in Google Scholar

14. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst. 1999;91(11 ):943-9.10.1093/jnci/91.11.94310359546Search in Google Scholar

15. SerovaOM, MazoyerS, PugetN, DuboisV,Tonin P, Shugart YY, et al. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet. 1997;60(3):486-95.Search in Google Scholar

16. LevenatS, Musani V, Cvok ML, Susac I, Sabo! M, Gzretic P, et al. Three novel BRCA1/BRCA2 mutations in breast/’ovarian cancer families in Croat ia.Gene. 2012;498(2):169-76.10.1016/j.gene.2012.02.01022366370Search in Google Scholar

17. Tucker JM, Rizk B. Hereditary female cancers: Breast, ovarian, and endometrial. Middle East Fertil Soc J. 2011;16(4):241-7.10.1016/j.mefs.2010.12.003Search in Google Scholar

18. National statistic institute [Internet]. Mortality by causes, sex and age. [cited 2013 Nov 2]. Available from: httpi/Zw'ww. nsi.bg’otrasal.php.'otr 22Search in Google Scholar

19. Cancer Research UK [Internet]. Breast cancer. Breast cancer incidence statistics, [updated 2012 Nov 7; cited 2013 Nov 2].Available from: http://www1.cancerreserchuk.org/cancer-info/cancerstats/types/breast/incidenece/uk-breast-cancer-incidenece-statisticsSearch in Google Scholar

20. Evans DGR, Fentiman IS, McPherson K, Asbury D, Ponder BAJ, Howell A Familial breast cancer. BMJ. 1994;308:183-7.Search in Google Scholar

21. Reis-Filho JS,Tutt AN. Triple negative tumours: a critical review. Hlstopathology. 2008;52( 1): 108-18.10.1111/j.1365-2559.2007.02889.x18171422Search in Google Scholar

22. Haffty BG.,Yang Q, Reiss M, KearneyT, Higgins SA, Weidhaas J, et al. Locoregkmal relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin On col. 2006;24(3 6):5652 -7.10.1200/JCO.2006.06.5664Search in Google Scholar

23. Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer. 2007;109(l):25-32.10.1002/cncr.22381Search in Google Scholar

24. Dent R, Trudeau M, Pritchard Kl, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical feature sand pat ter ns of recurrence. Clin Cancer Res. 2007;!3(15 Pt 1): 4429-34.10.1158/1078-0432.CCR-06-3045Search in Google Scholar

25. Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, Fulton RS, et al. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res. 2009; 11(3 ):R31.10.1186/bcr2261Search in Google Scholar

26. Lels HP Jr. Managing the remaining breast Cancer. 1980;46( Suppl 4): 1026-30.10.1002/1097-0142(19800815)46:4+<1026::AID-CNCR2820461327>3.0.CO;2-LSearch in Google Scholar

27. Adami HO, Bergstrom R, Hansen J. Age at first primary as a determinant of the incidence of bilateral breast cancer. Cancer. 1985;55(3):643-7.10.1002/1097-0142(19850201)55:3<643::AID-CNCR2820550328>3.0.CO;2-LSearch in Google Scholar

28. Engin K. Prognostic factors in bilateral breast cancer. Neoplasma. 1994;41(6):353-7.Search in Google Scholar

29. Rogozinska-Szczepka J, Utracka-Hutka B, Grzybowska E, Maka B, Nowicka E, Smok-Ragankiew'icz A, et al; BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients. Ann Oncol. 2004; 15(9): 13 73-6.10.1093/annonc/mdh352Search in Google Scholar

30. Palma MD, DomchekSM, Stopfer J, Erlichman J, Siegfried JD, Tigges-Cardwell J, et al. The relative contribution of point mutations and genomic rearrange me nts in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer res. 2008;68( 17):7006-14.10.1158/0008-5472.CAN-08-0599Search in Google Scholar

31. Gorski B, Narod S, Lubinski J. A common missense variant in BRCA2 predispose to early onset breast cancer. Breast Cancer Res. 2005;7(6):R 1023-7.10.1186/bcr1338Search in Google Scholar

32. Sliwinski T, Krupa R, Majsterek I, Rykala J, Kolacinska A, Morawiec Z, et al. Polymorphisms of the BRCA2 and R AD51 genes in breast cancer. Breast Cancer Res Treat. 200<S:94t2V 105-9 10.1007/s10549-005-0672-5Search in Google Scholar